首页> American journal of epidemiology> A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine.

A three-part model for the self-controlled case series design to estimate and characterize adverse event risk in an overlapping risk period after multiple vaccines: application to ischemic stroke following Pfizer-BioNTech bivalent COVID-19 vaccine and influenza vaccine.

导出 OA

翻译打印收藏纠错

第一作者： Stanley,Xu

第一单位： Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.;Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, United States.

作者： Stanley,Xu ^[1] ; Lina S,Sy ^[2] ; Xuan,Huang ^[2] ; Vennis,Hong ^[2] ; Bing,Han ^[2] ; Katia J,Bruxvoort ^[3] ; Bruno,Lewin ^[4] ; Kimberly J,Holmquist ^[2] ; Lei,Qian ^[2]

作者单位： Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.;Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, United States. ^[1] Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States. ^[2] Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.;Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, AL, United States. ^[3] Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, United States.;Department of Clinical Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, United States. ^[4]

关键词 coadministration influenza vaccines ischemic stroke mRNA COVID-19 vaccines overlapping risk period self-controlled case series simulation vaccine safety study